×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
Chemokine (C-C Motif) Ligand 2 (CCL2) Peptid
CCL2
Reaktivität: Säugetier
Wirt: Synthetic
BP, IHC, WB
Produktdetails
(ausblenden)
Target
Alle CCL2 Produkte
CCL2
(Chemokine (C-C Motif) Ligand 2 (CCL2))
Protein-Typ
Synthetic
Spezies
Säugetier
Quelle
Alle Wirte für CCL2 Peptide
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Sequenz
ASYRRITSSK CPKEAVIFKT IVAKEICADP KQKWVQDSMD HLDKQTQTPK
Produktmerkmale
A synthetic peptide for use as a blocking control in assays to test for specificity of CCL2 antibody, Alternative Names: CCL2 control peptide, CCL2 antibody Blocking Peptide, Anti-CCL2 Blocking Peptide, chemokine, C-C motif ligand 2 Blocking Peptide, GDCF-2 Blocking Peptide, GDCF-2 HC11 Blocking Peptide, HC11 Blocking Peptide, HSMCR30 Blocking Peptide, MCAF Blocking Peptide, MCP-1 Blocking Peptide, MCP1 Blocking Peptide, MGC9434 Blocking Peptide, SCYA2 Blocking Peptide, SMC-CF Blocking Peptide, CCL2, CCL-2, CCL 2, CCL-2 Blocking Peptide, CCL 2 Blocking Peptide
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Antigendetails
(ausblenden)
Target
CCL2
(Chemokine (C-C Motif) Ligand 2 (CCL2))
Synonyme
GDCF-2 Peptide, HC11 Peptide, HSMCR30 Peptide, MCAF Peptide, MCP-1 Peptide, MCP1 Peptide, SCYA2 Peptide, SMC-CF Peptide, AI323594 Peptide, JE Peptide, Scya2 Peptide, Sigje Peptide, MCP-1A Peptide, MCP1A Peptide, C-C motif chemokine ligand 2 Peptide, chemokine (C-C motif) ligand 2 Peptide, C-C motif chemokine 2 Peptide, CCL2 Peptide, Ccl2 Peptide, LOC101120093 Peptide
Hintergrund
CCL2 is a chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. CCL2 augments monocyte anti-tumor activity. CCL2 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. CCL2 may be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.
Molekulargewicht
11 kDa
Zuletzt angesehen
(ausblenden)